DeHeng Advised Energas on Obtaining Approval
from SSE for Major Asset Restructuring
2020-11-04
On November 3, 2020, the application of Hangzhou AGS MedTech Co., Ltd. ("AGS MedTech") for initial public offering of A shares and listing on the STAR Market of Shanghai Stock Exchange was approved at the 95th session of the STAR Market IPO Committee in 2020.
Established in 2010, AGS MedTech is specialized in design and development of products related to endoscopic minimally invasive diagnosis and treatment. It is a national high-tech enterprise capable of R&D, production, sales and services. Upholding the corporate core values of "creation, persistence, and sharing," it focuses on the needs of clinical users to provide patients and clinicians with safer and more efficient surgical solutions.
As the issuer's legal counsel, DeHeng team was led by partners Wu Lianming, Liu Xiuhua and Lou Jianjiang, with primary support from lawyers Feng Lin, Li Yingya and Mo Zhenxin and paralegal Wang Jieyun. They provided comprehensive, professional, efficient and high-quality legal services for the client. In the future, DeHeng will, as always, provide clients with high-quality legal services to facilitate their rapid development and help them find value in the capital market.
